M
Manuel Osorio
Researcher at Center for Biologics Evaluation and Research
Publications - 16
Citations - 647
Manuel Osorio is an academic researcher from Center for Biologics Evaluation and Research. The author has contributed to research in topics: Bacillus anthracis & Ty21a. The author has an hindex of 11, co-authored 16 publications receiving 613 citations.
Papers
More filters
Journal ArticleDOI
Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis
Niki M. Moutsopoulos,Heather M. Kling,Nikola Angelov,Wenwen Jin,Robert J. Palmer,Salvador Nares,Manuel Osorio,Sharon M. Wahl +7 more
TL;DR: The data unveil multiple pathways by which P. gingivalis may orchestrate chronic inflammation, providing insights into interventional strategies, and identifies immune cell-dependent mechanisms whereby bacterial challenge drives persistent destructive inflammation.
Journal ArticleDOI
Campylobacter jejuni Induces Maturation and Cytokine Production in Human Dendritic Cells
TL;DR: Data indicate that during infection, Campylobacter triggers an innate inflammatory response through increased production of IL-1β,IL-6, IL-8, and TNF-α and initiates a Th1-polarized adaptive immune response as predicted from the high level of production ofIL-12.
Journal ArticleDOI
Cytokine Response to Infection with Bacillus anthracis Spores
Alison K. Pickering,Manuel Osorio,Gloria M. Lee,Vanessa K. Grippe,Mechelle D. Bray,Tod J. Merkel +5 more
TL;DR: It is demonstrated that both mouse peritoneal macrophages and human dendritic cells exhibited significant intracellular bactericidal activity during the first hours following uptake, providing the necessary time to mount a cytokine response prior to cell lysis.
Journal ArticleDOI
Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines.
Satoshi Ohtake,Russell Martin,Atul Saxena,Binh Pham,Gary Chiueh,Manuel Osorio,Dennis J. Kopecko,De-Qi Xu,David Lechuga-Ballesteros,Vu Truong-Le +9 more
TL;DR: The enhanced heat stability of theTy21a oral vaccine, or Ty21a derivatives expressing foreign antigens (e.g. anthrax), could mitigate risks of vaccine potency loss during long-term storage, shipping, delivery to geographical areas with warmer climates or during emergency distribution following a bioterrorist attack.
Journal ArticleDOI
Anthrax Protective Antigen Delivered by Salmonella enterica Serovar Typhi Ty21a Protects Mice from a Lethal Anthrax Spore Challenge
Manuel Osorio,Yanping Wu,Sunil Singh,Tod J. Merkel,Siba Bhattacharyya,Milan S. Blake,Dennis J. Kopecko +6 more
TL;DR: The ultimate goal is a temperature-stable, safe, oral human vaccine against anthrax infection that can be self-administered in a few doses over a short period of time.